Authors
Loading...
RORγt inhibition reduces tumor growth in lung cancer, suggesting potential for inflammation management.
Yamada‐Hara et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: